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The concept of risk should be used carefully in addiction science, policy and debate due to its 
complexity and its potential to inform, distort or otherwise shape the perspectives of stakeholders, 
including the general public. Recent high-profile examples from the United Kingdom demonstrate 
that such care is often not being taken. 
The concept of risk plays a central role in addiction science, policy and debate. Risk is critical to our 
understanding of the harmfulness of addictive substances and behaviours and the design of 
appropriate preventative policies. However, risk is a complex concept. Its statistical malleability 
means presentation of risks in absolute or relative terms, or in comparison to potential harms of 
everyday activities, can inform, distort or otherwise stimulate debate [1]. Risks also do not exist only 
in numerical form. They are embodied through sensations of fear, apprehension, excitement and 
success. They are interpreted differently depending upon the communicator's credibility in the eyes 
of the recipient, such that past behaviours or institutional identities (e.g. industry or government) 
may undermine even robustly evidenced and appropriately communicated messages [2]. 
Professional and lay decision-making engage with risk but are subject to numerous biases and often 
limited statistical understanding [3]. Finally, risk is socially constructed through discourse, with 
reference to everyday activities, past experience and anomalous cases such as ‘the old lady who 
smoked every day but lived to a hundred’ [4]. 
 
Risk then, is to be treated carefully, perhaps more so in an age where political processes, journalism 
and scientific authority face major threats. Risk messages should be proportionately compelling and 
informed by an awareness of the probable and desired responses of recipients and conduits, such as 
news and social media. However, three high profile UK-based examples illustrate common failings: 
 
E-cigarettes: debate around e-cigarettes is partly a disagreement in good faith about how to respond 
to an external shock to tobacco control policy. The stakes are heightened by threats to professional 
identity as influence partially shifts from public health actors to vapers, markets and the tobacco 
industry. Nonetheless, claims about the risks of e-cigarettes have been starkly inconsistent. For 
example, the consensus-based statement by Public Health England that e-cigarettes are ‘95% safer’ 
than traditional cigarettes [5] has been attacked and defended in the Lancet and BMJ, with the 
dispute reported prominently in UK news outlets [6, 7]. 
Alcohol and cancer: in widely reported remarks, the Chief Medical Officer (CMO) for England told a 
UK parliamentary committee that people should decide each time they drink alcohol: ‘do I want my 
glass of wine or do I want to raise my risk of breast cancer?’ [8]. Setting aside the incorrectly stated 
choice and poor correspondence with evidence on the automatic and heuristically driven processes 
by which behavioural choices are typically made [9], similarly abstemious advice is offered by the 
World Cancer Research Fund (WCRF) who recommend ‘Don't drink alcohol’ as ‘any amount 
increases your [cancer] risk’ [10]. 
New psychoactive substances (NPS): the UK's Psychoactive Substances Act, 2016 subjects all non-
exempt NPS to control due to their psychoactivity rather than their potential harmfulness. While we 
acknowledge there are gaps in scientific data, the Act also presents risks from a diverse range of 
drugs (e.g. novel opioids and nitrous oxide) as equivalent [11]. 
These examples illustrate four problems with contemporary addiction-related risk discourse. 
 
First, there is a lack of attention to absolute levels of risk. Neither the CMO nor WCRF quantify risks 
alongside their statements. However, Cancer Research UK estimate that drinking a small glass of 
wine each day (approximately 12 g of alcohol) increases the average UK adult's absolute life-time 
risk of being diagnosed with mouth cancer from 0.5 to 0.6%, while the equivalent breast cancer risk 
for women would increase from 11.1 to 11.7% [12]. Given that a large proportion of drinkers 
consume less than this, that alcohol consumption at these levels may benefit cardiovascular health 
(albeit to a lesser extent and more selectively than some studies suggest) and that alcohol 
epidemiology is highly imprecise [13], the justification for alarmist or proscriptive guidance is 
unclear. 
 
Secondly, risk acceptability is rarely discussed explicitly despite its importance for judging when risks 
are managed adequately and campaigns for additional controls should stop [14]. For example, the 
World Health Organization has noted that e-cigarettes are ‘unlikely to be harmless’ [15], but 
unquestioned everyday activities, such as sports, travel and showering, also entail risks, so the value 
of harmlessness as a standard for judging risks is questionable [16]. For illicit drugs, discussion of risk 
acceptability is limited by poor understanding among the public and policymakers of their potential 
pleasures and harms, alongside often narrow frames for considering risks (e.g. overdose, addiction). 
In contrast, alcohol drinking guidelines have been set recently with reference to levels of risk 
apparently accepted for other activities (e.g. driving), but little direct evidence is available on 
acceptable risks from alcohol [13, 17]. 
 
Thirdly, a tension exists between population- and individual-level risk. Rose's influential prevention 
paradox demonstrates that small behavioural changes among low-risk individuals can produce large 
health gains for populations [18]. However, this logic of pooled risk reduction sits uneasily with the 
increased responsibility for health placed on individuals by policymakers in many high-income 
countries [19]. If individuals are to engage in, and be judged on, the active, life-long self-
management of their health, it is unclear how they should make use of often contradictory and 
incomplete information about small and uncertain risks associated with particular patterns and 
levels of addictive substance use. 
 
Finally, risk is experienced as well as measured. Lay epidemiological perspectives emphasize that 
public engagement with risk is not a statistical process but one rooted in biography, experience, 
context, discourse and bodily sensation [4]. Addictive substance use does not typically reflect a devil-
may-care attitude, but pleasurable sensations, an occasional reward to oneself or an environment 
where health warnings are received sceptically, in competition with other information or nor at all. 
Statements on risk which fail to account for this wider context may face rejection, distortion or being 
ignored. 
 Ultimately, these problems suggest a need for scientists, policymakers and public authorities to 
attend more to the complex nature of risk. The current focus on epidemiological statistics and 
persistence of normative practices which portray all risks as important to the public, irrespective of 
scale, certainty, nature and context, mean the greatest risks may be that people stop listening, that 
hard-earned scientific credibility is squandered and that policymaking staggers erratically between 
laissez-faire neglect and heavy-handed overkill. 
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